Financial Data and Key Metrics Changes - The company reported a 125% year-over-year increase in adjusted EBITDA, reaching $19.9 million, while gross profit increased by 1,349% to $20.5 million despite a top-line compression of $15.3 million or 7.9% [14][36] - For the fourth quarter, net sales from continuing operations were $40.7 million, slightly down from $41.2 million in the same quarter of 2023, with gross profit increasing to $7.3 million from a loss of $2.1 million [32][33] - The full-year net sales decreased to $177.9 million from $193.2 million in 2023, but gross profit rose significantly to $22.1 million from $1.5 million [36][37] Business Segment Data and Key Metrics Changes - In the tubular products segment, there was a year-over-year sales decline of $12.4 million, but segment-level gross profit increased by approximately $15 million due to cost management and product line optimization [16] - The specialty chemicals segment achieved its highest quarterly adjusted EBITDA since Q2 2022, driven by a 14% increase in gross margin despite moderate top-line compression [19][20] - Branded product sales in the specialty chemicals segment recorded a double-digit year-over-year increase, primarily driven by efforts in the oil and gas market [22] Market Data and Key Metrics Changes - The total addressable market for the specialty chemicals segment is over $9 billion, with a specific focus on branded products that offer faster cycle times and predictable demand [20] - The company noted a stronger order backlog in the tubular segment than it has seen in four years, indicating improving market dynamics [17] Company Strategy and Development Direction - The company plans to maximize the value of its assets in the tubular product segment while investing in profitable growth in the specialty chemicals segment [7][8] - There is a focus on organic growth within existing product portfolios and underutilized capabilities, with a commitment to high-potential strategic initiatives [25][24] - The company has expanded its stock repurchase program, allowing for the acquisition of up to an additional one million shares over the next 24 months [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's foundation and its ability to drive growth while maintaining operational excellence [8][10] - The outlook for top-line growth is more optimistic for the second half of 2025, with expectations of market share gains rather than market-driven growth [44] - Management highlighted the importance of domestic sourcing and supply chain optimization as a competitive advantage [57][58] Other Important Information - The company remains debt-free with $16 million in cash and $47 million available on its revolving credit facility, positioning it well for future investments [39] - A total of 101,263 shares were repurchased for approximately $1 million during the year [40] Q&A Session Summary Question: Where do you see top-line growth starting? - Management indicated that top-line growth is expected more in the second half of 2025, with any uptick likely due to market share gains rather than market recovery [44] Question: What contributed to the growth in cash from Q3 to Q4? - The increase in cash was primarily driven by optimizing idle inventory and improved cash conversion cycles [48][49] Question: Any updates on underutilized assets? - Management confirmed the sale of a smaller warehouse and mentioned ongoing efforts to find a permanent solution for other underutilized assets [52] Question: How is the new cleaning portfolio being accepted? - The reception was positive, with new opportunities being pursued following the launch at a cleaning conference [55] Question: Is there potential for further margin improvement in chemicals? - Management believes there is potential for ongoing margin improvement as branded product sales increase, although significant price increases are not anticipated for 2025 [61] Question: Is the share repurchase plan feasible? - Management stated that the plan provides optionality and is contingent on market conditions and share price [64] Question: Where do you see the company a year from now? - Management emphasized a pivot to growth, focusing on filling underutilized assets with high-value applications [68]

Financial Data and Key Metrics Changes - Consolidated revenue for the quarter was $700 million, down 9% year over year, but in line with expectations [10][19] - Adjusted earnings per share (EPS) was $0.56, down 19% year over year, consistent with expectations due to lower starting backlog [10][20] - Adjusted EBITDA was $97 million, a decrease of 15% year over year, with a consolidated adjusted EBITDA margin of 13.7%, down 110 basis points compared to the prior year [19][20] Business Line Data and Key Metrics Changes - Advanced Process Solutions (APS) revenue was $511 million, down 10% year over year, with adjusted EBITDA of $83 million, a decrease of 14% [21][22] - Molding Technology Solutions (MTS) revenue was $196 million, down 5% year over year, with adjusted EBITDA of $27 million, a decrease of 15% [23][24] - Backlog for APS was $1.6 billion, down 17% year over year, while MTS backlog increased 1% to $233 million [22][24] Market Data and Key Metrics Changes - North America and Europe markets remain sluggish, particularly in automotive, while Asia shows stability with growth in India [15][24] - Customer quote pipelines remain healthy, especially in India and Saudi Arabia, despite global macroeconomic uncertainty [12][36] Company Strategy and Development Direction - The company is focused on transforming its portfolio towards higher margin, higher growth, and less cyclical industrial leaders [6][8] - The sale of a 51% stake in Milacron for $287 million is part of this transformation, allowing the company to concentrate on core business and enhance shareholder value [6][26] - The company aims to maximize shareholder value by deleveraging and enhancing its margin profile [8][25] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth strategy despite ongoing macroeconomic pressures [17][31] - The company anticipates continued softness in North America and Europe in the near term, with expectations for improved performance as order decision timing normalizes [15][31] - Management remains optimistic about the potential for future returns from the Milacron business under Bain Capital's ownership [9][68] Other Important Information - The company expects to close the Milacron transaction by the end of the fiscal second quarter or early in the third quarter, with net proceeds used for debt pay down [26][27] - Updated fiscal year guidance reflects approximately $2.63 billion to $2.8 billion in revenue and adjusted EBITDA of $411 million to $447 million [28][29] Q&A Session Questions and Answers Question: What do customers need to see to move from quoting to placing orders? - Management indicated that geopolitical factors and clarity on interest rates are significant concerns for customers before making major investments [36] Question: What percentage of revenue does aftermarket represent and what is the outlook? - Aftermarket orders were close to 40% of total orders for the quarter, with expectations for continued improvement throughout the year [39][40] Question: What drove the decision to sell a majority stake in Milacron rather than a full divestiture? - The decision was based on a regular review of assets to determine the best return for shareholders, allowing Milacron to pursue growth opportunities while focusing on core businesses [54][55] Question: What are the expected EBITDA margins and free cash flow conversion capabilities post-divestiture? - Expected EBITDA margins for MTS are projected to be in the mid-20s, with a target of 100% free cash flow conversion in the medium term [58][73]